ITM Power’s Standardised Product Push and a Wave of Upcoming Decisions Reshape the Hydrogen Investment Case

ITM Power’s Neptune V orders, strategic partnerships, and narrowing losses drive stock to 156.70p, with analysts forecasting earlier EBITDA breakeven by FY2028.

ITM Power has entered a defining phase where product standardisation, government backing and a cluster of imminent catalysts are converging to give the hydrogen electrolyser maker a more repeatable business model. The London-listed stock touched a fresh 12-month high of 156.70 pence during the week, a far cry from the 44.50 pence trough recorded in the prior 52-week period, as investors digest a string of operational and financial milestones.

The company’s most visible success story is the Neptune V electrolyser system, a 5-megawatt containerised unit that has become the flagship product. In the six months to May 2025, ITM secured orders totalling 45 megawatts of Neptune V capacity, with distribution network operators and industrial gas providers driving demand. The shift away from bespoke engineering towards repeatable, modular solutions is precisely the kind of scalability the market has been demanding. A newer model, the ALPHA 50, is already showing early commercial traction and could replicate Neptune V’s sales trajectory.

Alongside product simplification, ITM is deepening its strategic partnerships. The joint venture with Rheinmetall, known as “Giga PtX”, plans to roll out a network of synthetic fuel plants across Europe. Each facility is designed for up to 50 MW of electrolysis capacity and will produce between 5,000 and 7,000 tonnes of e-fuel annually. The stated goal is to supply NATO member states with sovereign energy infrastructure, adding a defence-linked dimension to the hydrogen narrative.

Financial progress is equally central to the story. For the first half of its financial year ending October 2025, ITM reported record revenue of £18.0 million. The contracted order book stood at roughly £152 million, and a large proportion of those contracts are now profitable, improving the quality of earnings. Cash on hand at the half-year point was £197.8 million, though management expects the year-end cash balance to settle between £170 million and £175 million as capital expenditure continues.

Losses are narrowing. The full-year guidance for adjusted EBITDA remains a loss of £27 million to £29 million, which is around £4 million better than the prior year. Analysts at Zeus Capital have raised their revenue forecast for fiscal 2026 to a range of £40 million to £43 million. Morgan Stanley, meanwhile, now sees the company reaching EBITDA breakeven in fiscal 2028 — a full year earlier than previously anticipated — contingent on securing roughly 200 megawatts of new orders.

Investors are already pricing in a brighter outlook. The stock’s 12-month trading band of 44.00 pence to 179.70 pence has been skewed to the upper half, with the market capitalisation reaching approximately £1.11 billion. Trading activity on the day of the latest rally saw around 3.67 million shares change hands. The broader London hydrogen sector provided additional lift: Ceres Power Holdings surged 10.34 per cent on the same session, and AFC Energy also posted gains, reinforcing the narrative of fresh momentum for British clean-energy stocks.

The next leg of the story hinges on a cluster of near-term catalysts. June is shaping up to be a pivotal month. ITM is expected to take a final investment decision on the “Chronos” manufacturing line, which aims to produce stacks at lower cost and higher energy efficiency. The project is backed by £86.5 million in government support — £40 million in equity from Great British Energy and £46.5 million in grant funding from the UK Department for Energy Security and Net Zero — and targets a 1-gigawatt annual capacity at the Sheffield plant. Alongside the Chronos FID, the results of the UK’s Hydrogen Allocation Round 2 are due, and a final investment decision on Uniper’s 120-MW “Humber H2ub” project could serve as a sector-wide milestone.

ITM’s path to consistent profitability remains a work in progress. The company still expects an adjusted EBITDA loss for the full year, and the high valuation leaves little room for execution missteps. But the combination of standardised products, contracted order book improvements, and a packed decision calendar has given the rally a foundation that did not exist a year ago. The next formal checkpoint comes on 15 September 2026 with the release of preliminary results. If the board can confirm the trajectory toward profitable contracts and long-term service agreements, the current share price may prove to be just another staging post.